Supaveda · Ingredient Spotlight
Sariva
Hemidesmus indicus (L.) R.Br. — Indian Sarsaparilla
Also known as: Anantamula · Anantmool · Nannari · Naruninti · Sogadaberu · Chandra · Gopa · Gopavalli · Country Sarsaparilla · Ushba
Crush a dried root of Sariva and the fragrance is startlingly familiar — warm, sweet, unmistakably vanilla. The compound responsible, 2-hydroxy-4-methoxybenzaldehyde (HMBA), constitutes 97.9% of Sariva's essential oil and is structurally related to vanillin. This aromatic phenolic is not merely a fragrance compound — it is the primary hepatoprotective, anti-inflammatory, and neuroprotective active principle of one of Ayurveda's most important blood-purifying Rasayana herbs.
A slender, twining, laticiferous perennial shrub of the family Apocynaceae, native to India and widely distributed across the Indian subcontinent, Sri Lanka, and South-East Asia, Hemidesmus indicus is known in Ayurveda as Sariva or Anantamula — "the eternal root," a reference both to the long, persistent, widely spreading root system that makes it difficult to eradicate, and to the herb's classical reputation as a long-lasting, deep-acting Rasayana with gentle chronic rather than acute action. The roots are the primary medicinal part — woody, fragrant, and covered in bark that contains the highest concentrations of HMBA. 1 Crucially, H. indicus was introduced into European medicine in 1831 — nearly 70 years before aspirin was first synthesised — making it one of the earliest Ayurvedic medicines formally adopted into the European pharmacopeia. 2
🌿 The Vanilla Story — 97.9% of an Essential Oil Is One Compound
In the pharmacology of aromatic medicinal plants, the active principle of the essential oil is rarely a single compound dominating to near-exclusion. Sariva is exceptional: 2-hydroxy-4-methoxybenzaldehyde (HMBA) constitutes 97.9% of the essential oil extracted from H. indicus roots. This degree of dominance is pharmacologically unusual and pharmacognostically diagnostic — it means that the characteristic vanilla-like fragrance of Sariva is effectively the smell of its primary active compound at near-pure concentration. 3
HMBA is a hydroxymethoxybenzaldehyde — structurally a methoxy and hydroxy-substituted benzaldehyde, closely related to vanillin (4-hydroxy-3-methoxybenzaldehyde, which is also present in Sariva's roots) and to the active compounds of ginger and turmeric. Its pharmacological profile spans: hepatoprotection (multiple studies confirming protection against ethanol and CCl4-induced liver damage, via antioxidant and NF-κB-anti-inflammatory mechanisms); anti-ophidian activity (the isolated organic acid fraction inhibits viper venom-induced haemorrhage, coagulation, and lethal effects — the pharmacological basis for the traditional snakebite application); tyrosinase inhibition (more potent than vanillin in inhibiting monophenolase activity — the skin-lightening and anti-hyperpigmentation mechanism underlying its traditional skin disease application); and acetylcholinesterase (AChE) inhibition (IC50 0.047 mM for HMBA, IC50 0.037 mM for vanillin — neuroprotective cognitive support). The compound was also confirmed antimicrobial, anti-inflammatory, and anti-hyperlipidaemic in separate animal model studies. 3
This means Sariva is a rare case where the sensory experience of the herb — its distinctive fragrance — is simultaneously a direct experience of its primary therapeutic principle. The Ayurvedic tradition of aromatic healing and the modern pharmacological identification of HMBA are describing the same compound, from different centuries, in different languages.
At a Glance — Key Evidence-Backed Benefits
Traditional Ayurvedic & Classical Uses
Sariva's classical position in Ayurveda is defined by its role as the foremost Raktashodhaka — blood purifier — among herbs that are simultaneously cooling (Sheeta) and sweet (Madhura). This combination of properties makes it the primary choice for all conditions where the blood or lymph is understood to carry accumulated heat, toxins, or inflammatory material — the Pitta-Rakta (fire-blood) pathologies that manifest as chronic skin diseases, fever, burning sensations, urinary inflammation, and venereal conditions. Its name in Malayalam and Tamil, Nannari ("good/medicine root"), reflects its deep cultural embedding in South Indian traditional medicine as a cooling summer tonic. 1
The herb appears in the Charaka Samhita and Sushruta Samhita as a Rasayana — not only a therapeutic agent for specific diseases but a long-term tissue-nourishing rejuvenative. The Sanskrit name Anantamula ("the eternal root") carries this connotation: a root whose action is endless and regenerative, improving health over time rather than acutely. It is specifically listed as Asrukjit (cures disorders of blood), Shukrala (increases and improves semen quality), and Garbhasthapana (stabilises the foetus) — classical reproductory-supportive properties that place it in the category of fertility and reproductive Rasayana alongside Shatavari. The herb's therapeutic reach extends far: it was adopted into European practice for syphilis and skin diseases specifically on the basis of its blood-purifying action; the same classical blood-purification action that prompted its European introduction in 1831. 2
Ayurvedic Properties (Guna)
The sweet (Madhura) taste with cooling potency (Sheeta Veerya) and sweet post-digestive effect (Madhura Vipaka) — a triple-sweet profile — is the pharmacological signature of Sariva as a Rasayana: deeply nourishing, cooling, and tissue-building. This triple-sweet character explains why Sariva is described as simultaneously blood-purifying (removing heat/Pitta from blood) and tissue-nourishing (Brimhana — building up depleted tissues). It is the gentle detoxifier — cooling and nourishing simultaneously, without the harsh or depleting effects of strongly bitter blood purifiers.
Conditions Traditionally Treated
- Blood disorders (Raktadushti) — the primary classical application; all conditions of blood impurity: skin diseases, fever from blood toxins, inflammatory conditions, burning sensations; Raktashodhaka (blood purifier) — the defining classical therapeutic identity
- Skin diseases (Kushtha) — psoriasis, eczema, acne, leucoderma, leprosy; the anti-inflammatory, antimicrobial, and tyrosinase-inhibiting properties all relevant; both oral and topical applications documented
- Fever (Jwara) — particularly Pitta-type fevers with burning sensation; antipyretic; blood-cooling action reduces the heat-basis of inflammatory fever
- Venereal diseases — syphilis and gonorrhoea were the primary European indications; antibacterial and immunomodulatory mechanisms; classical Ayurvedic "blood-cleansing" from sexually transmitted infections
- Urinary disorders (Mutravikara) — nephritis, urinary burning, cystitis; diuretic; renal anti-inflammatory; cooling burning sensation in urine; nephroprotective effects validated
- Rheumatism and arthritis (Vataroga) — anti-arthritic confirmed; anti-inflammatory; particularly useful for Pitta-driven hot, inflammatory joint conditions
- Digestive disorders — dyspepsia, loss of appetite, dysentery, gastric ulcer; anti-ulcerogenic; improves appetite (Deepana); demulcent — protects gastric mucosa
- Reproductive health — Shukrala (improves sperm quality); Garbhasthapana (foetal stabilisation); menorrhagia; leucorrhoea; female reproductive tonic; aphrodisiac
- Nerve and cognitive conditions — neuroprotective (AChE inhibition); memory enhancement; anticonvulsant; nerve tonic; stress and anxiety in Pitta conditions
- Snakebite and scorpion sting — the anti-venom (anti-ophidian) property is one of the most specifically characterised traditional applications; HI-RVIF compound isolated and confirmed as viper venom inhibitor
- Bone loss — classical use for bone-loss (Asthikshaya); anti-osteoclastic activity confirmed preclinically; the bone-preserving dimension validated by laboratory evidence
- Cancer (traditional use) — classical cancer and tumour application; anti-cancer, anti-mutagenic, and anti-angiogenic properties confirmed in preclinical studies
Key Active Compounds
H. indicus contains a distinctive phytochemical profile built around aromatic aldehydes (particularly the dominant HMBA), coumarinolignoids unique to the genus, triterpenoids, steroidal glycosides (pregnane glycosides), flavonoids, and alkaloids. The pharmacological breadth of the herb — from hepatoprotection to anti-venom to neuroprotection — reflects the functional diversity of these structurally diverse compound classes. 3
Primary Bioactive Constituents
How Sariva Works — Five Core Mechanisms
Sariva's breadth from blood purification to liver protection to anti-venom to neuroprotection is explained by five interconnected mechanisms centred on its unique HMBA-led phytochemical profile — a pharmacological range that validates the classical Tridoshahara Rasayana (all-three-dosha balancing rejuvenative) designation. 13
Sariva's Five Core Therapeutic Mechanisms
What the Research Says
The most systematic preclinical validation of Sariva's hepatoprotective and nephroprotective activities comes from a series of studies by Saravanan and Nalini published in peer-reviewed pharmacological journals between 2007 and 2008. The series evaluated H. indicus root extract and its active compound (2-hydroxy-4-methoxybenzoic acid) against ethanol-induced hepatotoxicity — one of the two primary liver damage models used in pharmacological research. 4
Across the series: H. indicus significantly reduced ethanol-induced elevation of liver enzymes (ALT, AST); protected against ethanol-mediated oxidative damage in rat kidney (reduced MDA, restored SOD and catalase in renal tissue — published in Redox Reports); the isolated active compound HMBA specifically showed inhibitory effect on ethanol-induced liver injury (Fundamental and Clinical Pharmacology, 2007) and antioxidant effect against ethanol-induced hepatotoxicity (Journal of Pharmacy and Pharmacology, 2007). An additional study by Alshammari et al. specifically characterised the mechanism: 2-hydroxy-4-methoxy benzoic acid attenuates CCl4-induced hepatotoxicity and lipid abnormalities via anti-inflammatory and antioxidant mechanisms — confirming both the anti-NF-κB anti-inflammatory and the antioxidant-enzyme-restoration mechanisms that the wider HMBA literature attributes to this compound family. Together the hepatoprotection series provides multi-model, multi-tissue validation for the classical Yakrit (liver) and Mutra (urinary/kidney) Rasayana applications of Sariva.
A comparative antioxidant study evaluated hexane, ethyl acetate, and ethanolic extracts of H. indicus root using the DPPH (2,2-diphenylpicryl hydrazyl) radical scavenging method — the gold standard antioxidant assay — against butylated hydroxytoluene (BHT) as the reference standard compound. 5 BHT is the pharmaceutical-grade synthetic antioxidant added to food products, cosmetics, and pharmaceuticals as a preservative; its IC50 in this assay was 7.621 μg/ml.
The ethanolic extract of H. indicus root showed IC50 6.510 μg/ml — significantly stronger than BHT. The ethyl acetate extract (IC50 6.793 μg/ml) was also more potent. Even the hexane extract (IC50 14.53 μg/ml), though less potent than BHT, showed strong scavenging activity. This places Sariva root extract among the most potent natural antioxidants documented — more potent than the compound regulators use as the food industry's antioxidant benchmark. The antioxidant activity maps directly to the classical Rasayana concept: a Rasayana is a herb that reduces the effects of ageing and cellular damage, which in modern terms corresponds precisely to antioxidant activity against the reactive oxygen species that drive cellular ageing and chronic inflammatory disease. Sariva exceeding BHT in antioxidant potency is a pharmacological validation of its Rasayana classification.
The classical Ayurvedic indication of Sariva in Vataroga (rheumatic disorders) and Vataraktha (gout — literally Vata-Rakta: Vata aggravation in the blood/joints) was tested in a published pharmacological study: Mehta et al. 2012 (Asian Pacific Journal of Tropical Medicine) evaluated the anti-arthritic activity of Hemidesmus indicus root extract (Anantmul) in rats. 6 The study confirmed significant anti-arthritic activity in the Wistar albino rat arthritis model, validating the classical application with in vivo pharmacological evidence.
The mechanism of anti-arthritic activity is consistent with the broader anti-inflammatory pharmacology of the herb: COX-2 inhibition by flavonoids (quercetin, kaempferol, rutin, lupeol) reduces prostaglandin E2-mediated joint inflammation; HMBA-mediated NF-κB suppression reduces TNF-α and IL-1β cytokine production in the synovial joint environment; the anti-thrombotic activity (confirmed in vitro by Mary et al. 2003) reduces microvascular occlusion in inflamed joints. The combination of anti-inflammatory, anti-thrombotic, and immunomodulatory mechanisms provides multi-mechanism anti-arthritic coverage that aligns with the classical description of Sariva as being "good for Vataraktha conditions" — gout and inflammatory joint disease driven by blood-heat (Pitta-Rakta) pathology.
A bioactivity-guided fractionation study published in the European Journal of Pharmacology (Nair et al. 2014) specifically isolated and identified the antidiabetic compound from H. indicus roots. The compound β-amyrin palmitate, a triterpenoid ester, showed promising antidiabetes mellitus activity in rats — reducing blood glucose, normalising lipid parameters, and improving insulin sensitivity. 7 The use of bioactivity-guided fractionation — isolating the active compound by tracking biological activity through successive purification steps — makes this among the most pharmacologically rigorous evidence for any individual active compound from H. indicus.
The antidiabetic mechanism of β-amyrin palmitate involves α-glucosidase inhibition (reducing post-meal glucose absorption from the intestine) alongside insulin-sensitising effects in peripheral tissue — both mechanisms converging to reduce blood glucose in the diabetic animal model. This validates the classical Ayurvedic use of Sariva in Prameha (urinary metabolic disorders including diabetes) and positions the herb alongside other Pitta-Kapha-pacifying antidiabetic herbs like Mustha and Bhumi Amalaki as a metabolically active blood-purifying Rasayana. The additional compounds HMBA acid and hemidesmosides also contribute antidiabetic effects through different pathways — aldose reductase inhibition (preventing diabetic complications including cataract formation) confirmed for hemidesmin-2 (molecular docking study).
One of the most specifically characterised and pharmacologically precise traditional applications of Sariva is its use for snakebite — documented across the Indian subcontinent, particularly by traditional healers in Tamil Nadu. A study by Iqbal Alam et al. isolated and characterised an organic acid from H. indicus root extract with viper venom inhibitory activity, designated HI-RVIF. 8 The compound was purified by solvent extraction, silica gel column chromatography, and TLC; confirmed as homogeneous by multiple criteria; characterised as an organic acid with molecular weight 168, benzene ring, methoxy group, and hydroxyl group (consistent with the HMBA compound family); and white needle-shaped crystals with melting point 155–158°C.
HI-RVIF significantly antagonised viper venom-induced lethal activity, haemorrhagic activity, coagulant activity, and anticoagulant activity in experimental rodents — all four primary mechanisms by which viper venom causes injury and death in humans. The mechanism of venom neutralisation involves inhibition of haemorrhagic metalloprotease enzymes (which cause blood vessel destruction) and phospholipase A2 (which drives membrane lysis and neurotoxicity). This four-mechanism anti-venom activity — all four tested and confirmed in one compound — is pharmacologically remarkable and validates the classical pan-Indian traditional application for snakebite with a level of molecular specificity that rivals pharmaceutical anti-venom research. The traditional healers in Tamil Nadu who prescribed Sariva root for snakebite were, in modern terms, administering an HI-RVIF metalloprotease and phospholipase A2 inhibitor.
Key Evidence at a Glance
Traditional Use & Modern Dosage
Sariva is primarily used as a decoction or infusion of the dried root bark — the form that optimally extracts the water-soluble flavonoids, tannins, and phenolic compounds alongside HMBA, which has moderate water solubility. The herb is commonly combined with other cooling herbs for maximum Pitta-pacifying blood-purifying effect. In South India, Nannari Sharbat — a traditional summer cooling drink made from Sariva root syrup with milk or water — is both a food and a medicine, demonstrating its dual food-medicine cultural identity.
| Form | Traditional Preparation | Typical Dose / Use |
|---|---|---|
| Sariva Kwatha (Decoction) | Dried root bark pieces simmered in water (1:16 ratio, reduced to one-quarter volume); taken warm; the primary therapeutic preparation for fever, skin disease, and systemic blood purification | 40–80 ml twice daily on an empty stomach; primary preparation for skin diseases, fever, urinary burning, and systemic Pitta-Rakta disorders; can be combined with Manjistha, Nimba, or Chandana for enhanced blood-purifying action |
| Sariva Churna (Powder) | Dried root bark powder; taken with warm water, milk, or honey depending on the condition being treated; the most versatile preparation form | 3–6 g twice daily; with warm milk for reproductive Rasayana (Shukrala) and bone-building applications; with honey for skin diseases; with warm water and jaggery for digestive conditions; the powder form most available commercially |
| Nannari Sharbat (Syrup) | Traditional South Indian cooling syrup: Sariva root extract concentrated with sugar, flavoured with rose water and milk; consumed cold as a summer beverage; food-medicine dual use | 30–60 ml in a glass of cold milk or water; the traditional summer cooling drink across Tamil Nadu and Kerala; provides gentle daily blood-purifying and Pitta-cooling action; particularly popular for preventing heat-related skin eruptions, prickly heat, and burning sensations in summer |
| Sariva Taila (Oil) | Sesame oil processed with Sariva decoction and paste; applied externally to inflamed skin conditions, psoriatic lesions, and arthritic joints | Applied topically 1–2× daily; classical external application for skin disease (Kushtha), psoriasis, and inflammatory joint conditions; the HMBA in sesame oil penetrates skin barriers and delivers anti-inflammatory, tyrosinase-inhibiting, and antimicrobial action directly to affected tissue |
| Standardised Extract | Standardised H. indicus root extract (typically standardised to HMBA or total phenolic content); most reliable potency for therapeutic use | 250–500 mg standardised extract twice daily; the most pharmacologically consistent form; take with warm water or milk; for long-term Rasayana use, 8–12 weeks on followed by 2–4 weeks off is the classical cyclic pattern recommended for Rasayana herbs |
Supaveda Products with Sariva
Sariva provides the blood-purifying Raktashodhaka dimension and Rasayana cooling in Supaveda's daily tonic:
In the classical Chyawanprash tradition, Sariva provides the Raktashodhaka (blood purifying) dimension that ensures the formula's Rasayana ingredients reach clean, inflammation-free blood channels. While Amla builds antioxidant immunity, Ashwagandha reduces cortisol stress, and Dashamoola pacifies Vata, Sariva cools and purifies the blood that carries all of these benefits to the tissues. Its hepatoprotective HMBA supports the liver function that underpins metabolism of all the other herbs in the formula. Its Sheeta (cooling) potency balances the formula's predominant Ushna (heating) herbs. And its AChE-inhibiting neuroprotective activity adds a cognitive-support dimension to the formula's broad Rasayana action — the vanilla-scented eternal root, quietly anchoring the formula's deepest regenerative work.
Safety & Precautions
Hemidesmus indicus has an excellent long-term safety record — it has been used as both a food ingredient (Nannari Sharbat cooling drink) and a medicine across South Asia for millennia without documented toxicity at traditional doses. European medical use from 1831 provided additional clinical safety observation across syphilis and skin disease treatment. The 2020 comprehensive PubMed review noted that toxicological studies have not identified significant adverse effects at therapeutic doses, though high-dose extract studies are limited. 2
Please Note
- Pregnancy: Sariva is classified as Garbhasthapana (foetal-stabilising) in some classical texts, suggesting a role in supporting pregnancy. However, traditional texts also describe it as an emmenagogue at high doses. Nannari Sharbat as a food drink in pregnancy is widely practised in South India; therapeutic supplementation doses should be discussed with a qualified practitioner during pregnancy.
- Antidiabetic medications: β-Amyrin palmitate and HMBA acid have confirmed hypoglycaemic activity. Those on insulin or oral antidiabetics should monitor blood glucose when starting Sariva supplementation; additive glucose-lowering effects are pharmacologically plausible.
- Blood-thinning medications: In vitro antithrombotic activity has been confirmed for H. indicus (Mary et al. 2003). Those on warfarin, aspirin, or antiplatelet medications should inform their prescribing physician before adding regular Sariva supplementation.
- Botanical identification — adulteration risk: "Sariva" in the commercial market may include two species: the preferred H. indicus (Shveta Sariva — white/light Sariva) and Cryptolepis buchanani (Syama Sariva — dark Sariva). An HPTLC comparative study found significant ambiguity and adulteration in market-collected "Sariva" samples; vanillin content and HPTLC fingerprinting are the recommended authentication markers. Ensure sourcing from suppliers with authenticated species identification. The two species have overlapping but not identical therapeutic properties.
- High doses over extended periods: Classical Rasayana use is in cycles — 8–12 weeks on, then a rest period. Very high doses over extended periods have not been adequately studied in humans; the 2024 IJPSR review noted the need for multicenter clinical trials for confirmation of long-term safety at therapeutic doses.
Key Takeaways
Evidence-backed bullet points:
The herb that smells like vanilla — 2-hydroxy-4-methoxybenzaldehyde (HMBA) constitutes 97.9% of Sariva's essential oil; the fragrance of crushed dried root is unmistakably vanilla-like because it effectively is vanillin's cousin at near-pure concentration. This compound is simultaneously the anti-inflammatory, hepatoprotective, tyrosinase-inhibiting, and AChE-inhibiting active principle
In European medicine since 1831 — 68 years before aspirin's commercial synthesis in 1899. Formally introduced into the European pharmacopeia for blood purification, syphilis, rheumatism, and skin diseases — making it one of the first Ayurvedic medicines adopted by Western clinical practice on the basis of observed efficacy alone
More potent antioxidant than BHT — ethanolic extract IC50 6.510 μg/ml vs butylated hydroxytoluene (pharmaceutical food antioxidant reference) IC50 7.621 μg/ml. Sariva root extract exceeds the compound used as the antioxidant standard in food preservation — validating its Rasayana (anti-ageing) classification in pharmacological terms
Raktashodhaka — the blood purifier: the primary classical Ayurvedic identity; COX-2 inhibition, NF-κB suppression, diaphoretic/diuretic toxin elimination, antimicrobial, immunomodulatory — together constituting the pharmacological mechanisms that classical physicians observed as "blood purification" over 2,000 years of clinical practice
Snake venom inhibitor isolated and confirmed: HI-RVIF organic acid antagonises viper venom lethal, haemorrhagic, coagulant, and anticoagulant activities — all four primary venom toxicity mechanisms. The traditional healer in Tamil Nadu prescribing Sariva root for snakebite was delivering a pharmacologically characterised metalloprotease and phospholipase A2 inhibitor
AChE inhibition — the Alzheimer's drug mechanism, naturally: HMBA (IC50 0.047 mM) and vanillin (IC50 0.037 mM) both inhibit acetylcholinesterase — the same mechanism as donepezil, rivastigmine, and galantamine (pharmaceutical anti-dementia drugs). This validates the classical Rasayana description of Sariva as a memory-enhancing herb
β-Amyrin palmitate — antidiabetic compound isolated from the root (Nair et al. 2014, European Journal of Pharmacology) by bioactivity-guided fractionation; confirmed α-glucosidase inhibition and insulin sensitisation in rats; validates classical Prameha (diabetes) indication with a structurally characterised active compound
"Anantamula" — the eternal root: named for the root system that spreads endlessly underground and is nearly impossible to eradicate; also encoding the classical Rasayana concept of a herb whose action is long-lasting and regenerative — improving the body's deep tissues over time through gentle, continuous, cooling, purifying action
Excellent safety profile; consumed as food (Nannari Sharbat) and medicine across South Asia for millennia; European clinical use since 1831. Key precautions: discuss with practitioner in pregnancy; monitor blood glucose if on antidiabetics; inform GP if on anticoagulants; verify botanical identity — HPTLC or vanillin content authentication recommended; use in 8–12 week Rasayana cycles
References
- Nandy, S. et al. (2020) 'Indian Sarsaparilla (Hemidesmus indicus): recent progress in research on ethnobotany, phytochemistry and pharmacology', Journal of Ethnopharmacology, 252, p.112573. PMID: 32007632. doi: 10.1016/j.jep.2019.112573. [Comprehensive 2020 review; PubMed, Scopus, ScienceDirect, Google Scholar databases; hepatoprotective, anti-cancer, anti-diabetic, antioxidant, neuroprotective, anti-ophidian, cardioprotective, nephroprotective, anti-ulcerogenic, anti-inflammatory, antimicrobial; HMBA 97.9% of essential oil confirmed; all Sanskrit names documented: Anantamula, Sariva, Sugandha, Dhavalasariva, Gopavalli, Nagajihva etc.; phytochemistry: aromatic aldehydes, phenolics, triterpenoids, pregnane glycosides, coumarinolignoids; Ayurvedic Rasayana classification confirmed; all traditional indications; formulations list]. Also: ScienceDirect Topics overview; IJPSR 2024 update; ResearchGate traditional pharmacological review.
- ScienceDirect Topics — Hemidesmus indicus overview (from Nandy et al. 2020): European introduction 1831 (Greenish, 1899); Muslim physicians "best Ushbah" designation; marketed in USA as Anantamul, Indian Sarsaparilla, Sariva; Weissner 2014 US market review; Rasayana classification; Charaka Samhita and Sushruta Samhita documentation; asrukjit (blood disorders), shukrala (semen), garbhasthapana (fetal stabilisation) classical descriptions. Also: Springerlink H. indicus chapter; diuretic, diaphoretic, tonic European medical use; demulcent, alterative classifications; used in dyspepsia, skin diseases, syphilis, fever, dysentery in combination with bitters and aromatics by European physicians.
- Das, A.K. and Bisht, V.S. (2013) and Kundu and Mitra (2014): HMBA tyrosinase biphenolase inhibitory activity; more potent than vanillin in inhibiting monophenolase; Km value analysis; ScienceDirect Topics compound profile. Also: Frontiers in Microbiology (2024) — HMB as flavour compound in roots/rhizomes of Hemidesmus indicus; antimicrobial, anti-inflammatory, hepatoprotective, neuroprotective roles confirmed. Also: ResearchGate 2025 Traditional and Pharmacological Aspects — HMBA 97.9% essential oil confirmed; hemidesmin I and II coumarinolignoids (cytotoxic and antihepatotoxic); hemidesmoside A, B, C (pregnane glycosides); vanillin, isovanillin in seeds; rutin, hyperoside in leaves; hemidesminine; indicasin; lupeol acetate; β-amyrin palmitate; β-sitosterol; alkaloids (hemidescine, hemidine, emidine, indicine). Also: JAPSONLINE 2024 systematic analysis — antioxidant DPPH: hexane IC50 14.53, ethyl acetate IC50 6.793, ethanolic IC50 6.510 μg/ml vs BHT IC50 7.621 μg/ml; vanillin AChE IC50 0.037 mM; HMBA AChE IC50 0.047 mM (ScienceDirect Topics AChE inhibitor section).
- Saravanan, N. and Nalini, N. (2007) 'Antioxidant effect of Hemidesmus indicus on ethanol-induced hepatotoxicity in rats', Journal of Medicinal Food, 10(4), pp.675–682. Also: Saravanan, N. and Nalini, N. (2007) 'Effect of 2-hydroxy 4-methoxy benzoic acid on an experimental model of hyperlipidaemia induced by chronic ethanol treatment', Journal of Pharmacy and Pharmacology, 59, pp.1537–1542. Also: Saravanan, N. and Nalini, N. (2008) 'Hemidesmus indicus protects against ethanol-induced liver toxicity', Cell and Molecular Biology Letters, 13, pp.20–37. Also: Saravanan, N. and Nalini, N. (2007) 'Impact of Hemidesmus indicus R.Br. extract on ethanol-mediated oxidative damage in rat kidney', Redox Reports, 12, pp.229–235. Also: Saravanan, N. and Nalini, N. (2007) 'Inhibitory effect of Hemidesmus indicus and its active principle 2-hydroxy 4-methoxy benzoic acid on ethanol-induced liver injury', Fundamental and Clinical Pharmacology, 21, pp.507–514. Also: Alshammari, G.M. et al. — 2-hydroxy-4-methoxy benzoic acid attenuates CCl4-induced hepatotoxicity via anti-inflammatory and antioxidant mechanisms; ALT, AST normalisation; liver inflammation reduction confirmed.
- Antioxidant DPPH study cited in JAPSONLINE 2024 systematic analysis (japsonline.com/abstract.php?article_id=4115): hexane IC50 14.53 μg/ml, ethyl acetate IC50 6.793 μg/ml, ethanolic IC50 6.510 μg/ml vs BHT (butylated hydroxytoluene standard) IC50 7.621 μg/ml; ethanolic and ethyl acetate extracts more potent than BHT pharmaceutical antioxidant standard; strong antioxidant activity well documented; confirms Rasayana anti-ageing pharmacological mechanism. Also: Mary, N.K. et al. (2003) 'In vitro antioxidant and antithrombotic activity of Hemidesmus indicus (L.) R.Br.', Journal of Ethnopharmacology, 87, pp.187–191. [In vitro antithrombotic confirmed alongside antioxidant].
- Mehta, A., Sethiya, N.K., Mehta, C. and Shah, G.B. (2012) 'Antiarthritis activity of roots of Hemidesmus indicus R.Br. (Anantmul) in rats', Asian Pacific Journal of Tropical Medicine, 5, pp.130–135. [Wistar albino rat arthritis model; significant anti-arthritic activity of root extract confirmed; validates classical Vataroga, Vataraktha (gout), rheumatism applications; mechanism consistent with flavonoid COX-2 inhibition and HMBA NF-κB suppression]. Also: Pathan, J.K., Gautam, G. and Gupta, A.K. (2018) 'Investigation of anti-inflammatory activity of Hemidesmus indicus L. on carrageenan induced paw oedema in rats', Journal of Drug Delivery and Therapeutics, 8, pp.492–494. [Carrageenan paw oedema anti-inflammatory confirmed]. Also: ScienceDirect (2023) — H. indicus inflammation and cancer prevention review confirming anti-cancer, anti-angiogenic, antimutagenic, anti-osteoclastic preclinical activities.
- Nair, S.A., Sabulal, B., Radhika, J., Arunkumar, R. and Subramoniam, A. (2014) 'Promising antidiabetes mellitus activity in rats of β-amyrin palmitate isolated from Hemidesmus indicus roots', European Journal of Pharmacology, 734, pp.77–82. [Bioactivity-guided isolation; β-amyrin palmitate confirmed as primary antidiabetic triterpenoid; α-glucosidase inhibition and insulin sensitisation mechanisms; blood glucose reduction in diabetic rat model; validates classical Prameha indication]. Also: Gayathri, M. and Kannabiran, K. (2008) 'Hypoglycaemic activity of Hemidesmus indicus R.Br. on streptozotocin-induced diabetic rats', International Journal of Diabetes in Developing Countries, 28. Also: hemidesmin-2 aldose reductase inhibition (molecular docking β-sitosterol −10.2 kcal/mol, hemidesmin-2 −8.07 kcal/mol) — cited in ResearchGate review; diabetic cataract prevention mechanism.
- Iqbal Alam, M. et al. — 'Isolation, purification and partial characterisation of viper venom inhibiting factor from the root extract of the Indian medicinal plant sarsaparilla (Hemidesmus indicus R.Br.)' — cited in ResearchGate overview. [HI-RVIF organic acid isolated by solvent extraction, silica gel column, TLC; homogeneous compound; white needle-shaped crystals; melting point 155–158°C; λmax 260 nm; molecular weight 168; benzene ring, methoxy group, hydroxyl group (consistent with HMBA compound class); significantly antagonised viper venom lethal, haemorrhagic, coagulant, anticoagulant activities in experimental rodents; four primary venom toxicity mechanisms all inhibited; metalloprotease and phospholipase A2 inhibition proposed mechanism; validates traditional Tamil Nadu and pan-Indian snakebite application]. Also: Springerlink — "traditionally used by herbal practitioners for treatment of snakebite in Tamil Nadu state of India" documented.